Induction of scattering and cellular invasion by trefoil peptides in src- and RhoA-transformed kidney and colonic epithelial cells

FASEB Journal

Volumn 15, Issue 2, 2001, Pages 351-361

  Emami, Shahin ^a   Le Floch, Nathalie ^a   Bruyneel, Erik ^b   Thim, Lars ^c   May, Felicity ^d   Westley, Bruce ^d   Rio, Marie Christine ^e   Mareel, Marc ^b   Gespach, Christian ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c NOVO NORDISK A S   (Denmark)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e INSERM   (France)

Author keywords

Inflammation; ITF; Phospholipase C; PI3 kinase; pS2; Rapamycin; SP

Indexed keywords

TREFOIL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; CELL LINE, TRANSFORMED; CELL MOVEMENT; COLLAGEN; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DOGS; ENZYME INHIBITORS; GENES, SRC; GROWTH SUBSTANCES; HUMANS; INTESTINAL MUCOSA; KIDNEY; MUCINS; MUSCLE PROTEINS; NEOPLASM INVASIVENESS; NEUROPEPTIDES; PEPTIDES; PRECANCEROUS CONDITIONS; RECOMBINANT PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; UROTHELIUM;

ANIMALIA; LOTUS;

EID: 0035128299     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.00-0355com     Document Type: Article

References (64)

1. A new family of growth-factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins)
2. The trefoil peptide family
3. Dimerization of human pS2 (TFF1) plays a key role in its protective/healing effects
4. Trefoil peptides promote epithelial migration through a transforming growth factor β-independent pathway
5. Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats
6. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage
7. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
8. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein
9. Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis
10. Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract
11. Differential expression of the pS2 protein in human prostate and prostate cancer: Association with premalignant changes and neuroendocrine differentiation
12. Expression of a breast-associated protein (pS2) in human neuro-endocrine tumors
13. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line
14. Activation of pS2 gene transcription is a primary response to oestrogen in the human breast cancer cell line MCF-7
15. PS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins
16. The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach
17. The 5′flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein
18. Gastric carcinoma exhibits distinct types of cell differentiation: An immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)
19. Differential RNA expression of the pS2 gene in the human benign and malignant prostatic tissue
20. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells
21. Effects of growth factors and trefoil peptides on migration and replication in primary oxyntic cultures
22. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis
23. Phosphorylation of β-catenin and epidermal growth factor receptor by intestinal trefoil factor
24. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells
25. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells
26. Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells
27. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene
28. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: Cooperation between src and HGF/Met in invasion
29. Transition from the noninvasive to the invasive phenotype and loss of α-catenin in human colon cancer cells
30. Inhibition by platelet-activating factor of src., and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3′-kinase is a critical mediator of tumor invasion
31. Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K
32. Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase
33. Effects of regulated expression of mutant RhoA and Rac1 small GTPases on the development of epithelial (MDCK) cell polarity
34. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide (VIP) receptors in human breast cancer cells
35. VEGF, VEGF-B, VEGF-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa
36. Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast
37. Characterization of human and rat intestinal trefoil factor produced in yeast
38. Homodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58
39. Breast cancer-associated pS2 protein: Synthesis and secretion by normal stomach mucosa
40. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role
41. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, Rho- and Rac-dependent signaling pathways
42. pp60 (c-src) is required for cell locomotion regulated by the hyaluronan receptor RHAMM
43. c-src in progressive stages of human colorectal cancer
44. Activating SRC mutation in a subset of advanced human colon cancers
45. c-src activity in human colorectal metastases
46. Overexpression and amplification of the Met/HGF receptor gene during the progression of colorectal cancer
47. Large clostridial cytotoxins: A family of glyco-transferases modifying small GTP-binding proteins
48. Regulation of epidermal growth factor receptor traffic by the small GTPase Rho
49. Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering
50. Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility
51. Inhibition of PMA-induced, LFA-1-dependent lymphocyte aggregation by ADP ribosylation of the small molecular weight GTP binding protein, rho
52. Increased protein kinase Cα expression in human colonic Caco-2 cells after insertion of human Ha-ras of polyoma virus middle T oncogenes
53. Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis
54. Overactivation of phospholipase Cγ 1 renders platelet-derived growth factor β-receptor-expressing cells independent of the phosphatidylinositol 3-kinase pathway for chemotaxis
55. Activation of phospholipase Cγ by PI 3-kinase-induced PH domain-mediated membrane targeting
56. The 70 kDa S6 kinase complexes with and is activated by the Rho family G-proteins Cdc42 and Rac1
57. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
58. Evidence for the identity of human scatter factor and human hepatocyte growth factor
59. Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach
60. Identification and characterization of rat intestinal trefoil factor: Tissue- and cell-specific member of the trefoil protein family
61. Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ
62. Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease
63. The molecular architecture of focal adhesions
64. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers